Questcor Pharmaceuticals, which develops treatments for autoimmune and inflammatory disorders, has named Michael Aldridge senior vice-president, corporate strategic development. Prior to joining California, US-based Questcor, Mr Aldridge served as chief executive officer, managing director and board member of Australian biopharma, Xenome. He will report to Questcor’s chief operating officer, Steve Cartt.

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

Asia life science-focused VC firms*

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.